858 Therapeutics Funding & Investors
San Diego, CA
858 Therapeutics is a biotechnology and drug discovery company developing a portfolio of small molecule drugs that act on novel therapeutic targets in oncology, including proteins that regulate RNA and the innate immune response.
8five8tx.comTotal Amount Raised: $130,056,096
858 Therapeutics Funding Rounds
Series B
$50,000,000
Series B Investors
Avidity PartnersAlexandria Venture InvestmentsMirae Asset CapitalInsight Venture PartnersVersant VenturesNew Enterprise Associates (NEA)Logos CapitalSeries A
$60,000,000
Series A Investors
Versant VenturesLogos CapitalCormorant Asset ManagementNew Enterprise Associates (NEA)Series Unknown
$20,056,095
Funding info provided by Diffbot.